The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Publication

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2(Front. Immunol., (2022), 13, (889372), 10.3389/fimmu.2022.889372)


Author(s):

Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra Esparon, Ester Lopez, Klasina Chappin, Li Jin Chan, Francesca L. Mordant, Wen Shi Lee, Nicholas A. Gherardin, Sheila K. Patel, Gemma E. Hartley, Phillip Pymm, James P. Cooney, James G. Beeson, Dale I. Godfrey, Louise M. Burrell, Menno C. van Zelm, Adam K. Wheatley, Amy W. Chung, Wai Hong Tham, Kanta Subbarao, Stephen J. Kent, P. Mark Hogarth

Details:

Frontiers in Immunology, Volume 13, 2023-01-10, Article number 1122516

Article Link: Click here

Affiliations:

  • University of Melbourne
  • The Peter Doherty Institute for Infection and Immunity
  • Faculty of Medicine, Nursing and Health Sciences
  • Burnet Institute
  • Walter and Eliza Hall Institute of Medical Research
  • Monash University
  • The Alfred